Nurse Practitioner · Baltimore, MD
NPI
1184399131
Since 2021
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
827 Linden Ave
Baltimore, MD, 21201
Phone (410) 225-8369
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
428 services
Medicare patients, 2024
102
Average age 64
Drug cost, 2024
$4.1M
4,146 prescriptions
Company payments, 2024
$146
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Judith Lee was code 99214 (office e&m - established), 212 times for 84 patients. In total Judith Lee billed 428 services in 6 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 212 | 84 | $61.26 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 159 | 73 | $12.26 | $1,950 |
| 99215 Office E&M - Established | Facility | 51 | 45 | $93.44 | $4,766 |
By year: 2022 $12K for 220 services; 2023 $20K for 311 services; 2024 $20K for 428 services.
Medicare prescription drug claims, 2024
In 2024, the drug Judith Lee prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 518 prescriptions and refills. In total Judith Lee wrote 4,146 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 518 | 528 | 69 | $2.0M |
| Atorvastatin Calcium Generic | 405 | 522 | 62 | $1,925 |
| Losartan Potassium Generic | 188 | 214 | 28 | $582 |
| Amlodipine Besylate Generic | 178 | 216 | 28 | $144 |
| Lisinopril Generic | 169 | 207 | 24 | $552 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 115 | 123 | 14 | $444K |
| Tivicay Dolutegravir Sodium | 105 | 105 | 11 | $263K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 88 | 94 | 20 | $3,362 |
| Dovato Dolutegravir Sodium/Lamivudine | 83 | 83 | 11 | $238K |
| Gabapentin Generic | 80 | 80 | 12 | $475 |
| Tamsulosin Hcl Generic | 74 | 76 | Under 11 | $446 |
| Fluticasone Propionate Generic | 71 | 86 | 18 | $917 |
| Juluca Dolutegravir/Rilpivirine | 67 | 69 | Under 11 | $232K |
| Ventolin Hfa Albuterol Sulfate | 64 | 66 | 13 | $3,666 |
| Hydrochlorothiazide Generic | 60 | 74 | 11 | $184 |
Brand drugs: 1,497 claims; generic drugs: 2,637 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Judith Lee $146 ($146 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $122.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.